Canopy Growth Corp (NASDAQ:CGC) — Market Cap & Net Worth
Market Cap & Net Worth: Canopy Growth Corp (CGC)
Canopy Growth Corp (NASDAQ:CGC) has a market capitalization of $405.06 Million ($405.06 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13511 globally and #3211 in its home market, demonstrating a -6.08% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Canopy Growth Corp's stock price $0.96 by its total outstanding shares 422819025 (422.82 Million). Review CGC total debt and obligations to assess the company's total debt and financial obligations.
Canopy Growth Corp Market Cap History: 2015 to 2026
Canopy Growth Corp's market capitalization history from 2015 to 2026. Data shows change from $9.09 Billion to $405.06 Million (-23.54% CAGR).
Index Memberships
Canopy Growth Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.02% | #355 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #1303 of 3165 |
Weight: Canopy Growth Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Canopy Growth Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Canopy Growth Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.79x
Canopy Growth Corp's market cap is 1.79 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $28.84 Billion | $12.70 Million | -$3.50 Million | 2270.75x | N/A |
| 2017 | $100.02 Billion | $39.90 Million | -$16.61 Million | 2507.16x | N/A |
| 2018 | $113.61 Billion | $77.95 Million | -$54.13 Million | 1457.53x | N/A |
| 2019 | $89.17 Billion | $226.34 Million | -$670.09 Million | 393.97x | N/A |
| 2020 | $104.18 Billion | $398.77 Million | -$1.32 Billion | 261.26x | N/A |
| 2021 | $36.91 Billion | $546.65 Million | -$1.74 Billion | 67.52x | N/A |
| 2022 | $9.77 Billion | $475.70 Million | -$310.04 Million | 20.53x | N/A |
| 2023 | $2.16 Billion | $333.25 Million | -$3.28 Billion | 6.48x | N/A |
| 2024 | $1.16 Billion | $297.15 Million | -$657.27 Million | 3.90x | N/A |
| 2025 | $482.01 Million | $269.00 Million | -$598.12 Million | 1.79x | N/A |
Competitor Companies of CGC by Market Capitalization
Companies near Canopy Growth Corp in the global market cap rankings as of June 18, 2026.
Key companies related to Canopy Growth Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Canopy Growth Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Canopy Growth Corp's market cap moved from $9.09 Billion to $ 405.06 Million, with a yearly change of -23.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $405.06 Million | -15.96% |
| 2025 | $482.01 Million | -58.39% |
| 2024 | $1.16 Billion | -46.38% |
| 2023 | $2.16 Billion | -77.88% |
| 2022 | $9.77 Billion | -73.54% |
| 2021 | $36.91 Billion | -64.57% |
| 2020 | $104.18 Billion | +16.83% |
| 2019 | $89.17 Billion | -21.51% |
| 2018 | $113.61 Billion | +13.58% |
| 2017 | $100.02 Billion | +246.87% |
| 2016 | $28.84 Billion | +217.06% |
| 2015 | $9.09 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Canopy Growth Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $405.06 Million USD |
| MoneyControl | $405.06 Million USD |
| MarketWatch | $405.06 Million USD |
| marketcap.company | $405.06 Million USD |
| Reuters | $405.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such… Read more